Skip to search formSkip to main contentSkip to account menu

CDP 840

Known as: CDP-840, CDP840 
National Institutes of Health

Related topics

Related topics

1 relation

Broader (1)

Pyridines

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2006
2006
Platform synthesis: A useful strategy for rapid and systematic generation of molecular diversity.
Emergence of library-based approaches have changed the way of developing new functional molecules in materials science and… 
2005
2005
Rapid synthesis of CDP840 with 2-pyrimidyl vinyl sulfide as a platform.
A rapid synthesis of CDP840 (a potential therapeutic agent for asthma), using 2-pyrimidyl vinyl sulfide as a platform, has been… 
2002
2002
Discovery of L-791,943: a potent, selective, non emetic and orally active phosphodiesterase-4 inhibitor.
2001
2001
Investigation of the in vitro metabolism profile of a phosphodiesterase-IV inhibitor, CDP-840: leading to structural optimization.
CDP-840 is a selective and potent phosphodiesterase type IV inhibitor, whose in vitro metabolism profile was first investigated… 
2000
2000
Phosphodiesterase activity in neutrophils from horses with chronic obstructive pulmonary disease.
2000
2000
Evidence to suggest that the phosphodiesterase 4 isoenzyme is present and involved in the proliferation of umbilical cord blood mononuclear cells
The type 4 phosphodiesterase (PDE) isoenzyme is the main isoenzyme of PDE involved in the control of adult mononuclear cell… 
1999
1999
Possible Contribution of Prostaglandin E2 to the antiproliferative effect of phosphodiesterase 4 inhibitors in human mononuclear cells.
1997
1997
The effect of the novel phosphodiesterase Type 4 inhibitor CDP840 on antigen and oxidant-induced airway responses.
Highly Cited
1996
Highly Cited
1996
The inhibition of antigen‐induced eosinophilia and bronchoconstriction by CDP840, a novel stereo‐selective inhibitor of phosphodiesterase type 4
1 The novel tri‐aryl ethane CDP840, is a potent and selective inhibitor of cyclic AMP phosphodiesterase type 4 (PDE 4) extracted… 
1996
1996
Effect of the glucocorticosteroid budesonide and a novel phosphodiesterase type 4 inhibitor CDP840 on antigen‐induced airway responses in neonatally immunised rabbits
1 The effects of the inhaled corticosteroid budesonide and a novel PDE 4 inhibitor CDP840 given systemically, were evaluated in a… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)